Schwarz Omeprazole On Track For $1 Bil.; Transforming Event For Company?
Executive Summary
Schwarz Pharma's generic omeprazole could generate over $1 bil. in sales in 2003
You may also be interested in...
Schwarz Omeprazole Strategy, Part 2: DTC Ads, No Further Price Cuts
Schwarz is giving generic omeprazole a marketing push into the broader proton pump inhibitor category rather than reducing price to further capture Prilosec's share in the omeprazole segment
Schwarz Omeprazole Strategy, Part 2: DTC Ads, No Further Price Cuts
Schwarz is giving generic omeprazole a marketing push into the broader proton pump inhibitor category rather than reducing price to further capture Prilosec's share in the omeprazole segment
Iraq War Rally Helps Rx Stocks; Investors Adjust To Diminished Expectations?
Pfizer's steady progress toward closing the Pharmacia acquisition is giving the company a winning profile on Wall Street against the backdrop of a broader market rally fueled by the U.S. war in Iraq